Articles published by Ocular Therapeutix, Inc.
![](https://mms.businesswire.com/media/20221108005353/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20221107005999/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ Reports Third Quarter 2022 Financial Results and Business Update
November 07, 2022
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20221024005315/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ To Report Third Quarter 2022 Financial Results
October 24, 2022
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220927005508/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20220922005225/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ To Present Data at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting
September 22, 2022
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220907006025/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ to Present at the H.C. Wainwright 24th Annual Global Investment Conference
September 07, 2022
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220810005126/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
August 10, 2022
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220808005585/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ Reports Second Quarter 2022 Financial Results and Business Update
August 08, 2022
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220725005204/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220608005369/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20220601005448/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220509006050/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220503006259/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20220426005386/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220425005249/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20220414005882/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20220222005137/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20220211005129/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20220118005422/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20220104005292/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
January 04, 2022
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20211206005259/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20211115005512/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ to Participate at Two Upcoming Investor Conferences
November 15, 2021
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20211109006077/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ Announces Success in Patent Appeal Brought by Mati Therapeutics, Inc.
November 09, 2021
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20211108006032/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ Reports Third Quarter 2021 Financial Results and Business Update
November 08, 2021
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20211105005537/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20211101005314/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ to Present Data at the American Academy of Optometry Annual Meeting 2021
November 01, 2021
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20211029005481/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ To Report Third Quarter 2021 Financial Results
October 29, 2021
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20211022005097/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20211011005575/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Via Business Wire
Tickers
OCUL
![](https://mms.businesswire.com/media/20210928005387/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ Announces Appointment of Karen-Leigh Edwards as Senior Vice President of Technical Operations
September 28, 2021
Via Business Wire
Tickers
OCUL
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.